Patent · US Active

Methods for sequencing samples

US12241129B2 · kind B2 · utility

0Cited by
134References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2023
Grant dateMar 4, 2025
Priority date
Expiry dateDec 8, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Personalized medicine involves the use of a patient's molecular markers to guide treatment regimens for the patient. The scientific literature provides multiple examples of correlations between drug treatment efficacy and the presence or absence of molecular markers in a patient sample. Methods are provided herein that permit efficient dissemination of scientific findings regarding treatment efficacy and molecular markers found in patient tumors to health care providers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.